Email this article 
Observation of oncohematologic patients by general pediatricians
- Authors: Varfolomeyeva S.R.1,2, Kachanov D.Y.1,2, Shneyder M.M.1, Dobrenkov K.V.1, Shamanskaya T.V.1,2, Samochatova Y.V.3, Rumyantzev A.G.3
-
Affiliations:
- Federal State Enterprise «Federal Research Clinical Center of Pediatric Hematology, Oncology and Immunology of Russian Public Health
- Moscow Regional Oncologic Dispensary
- Federal State Enterprise «Federal Research Clinical Center of Pediatric Hematology, Oncology and Immunology of Russian Public Health
- Issue: No 1-2 (2008)
- Pages: 63-69
- Section: QUALITY OF LIFE AND FOLLOW-UP
- Published: 23.05.2008
- URL: https://oncohematology.abvpress.ru/ongm/article/view/696
- DOI: https://doi.org/10.17650/1818-8346-2008-0-1-2-63-69
- ID: 696
Cite item
Full Text
Abstract
For past decades there have been substantial changes in the therapy of oncohematologic diseases in children. Today, the treatment of this subset of patients is impossible without close cooperation between pediatric oncology/hematology professionals and general pediatricians. Authors underline the following critical steps in the management of oncohematologic patients necessarily requiring participation of general pediatricians: early diagnosis of malignancies, management of patients during their anti-tumor treatment, observation of patients in complete remissions after effective anti-tumor treatment, management of patents receiving palliative care, organization of hospices. Issues regarding prophylaxis and treatment of infectious complications in oncohematologic patients, use of growth factors, substitutive treatment with blood components and vaccination are reviewed.
Keywords
About the authors
S. R. Varfolomeyeva
Federal State Enterprise «Federal Research Clinical Center of Pediatric Hematology, Oncology and Immunology of Russian Public Health; Moscow Regional Oncologic Dispensary
Author for correspondence.
Moscow
Balashikha
Russian FederationD. Yu. Kachanov
Federal State Enterprise «Federal Research Clinical Center of Pediatric Hematology, Oncology and Immunology of Russian Public Health; Moscow Regional Oncologic Dispensary
Moscow
Balashikha
Russian FederationM. M. Shneyder
Federal State Enterprise «Federal Research Clinical Center of Pediatric Hematology, Oncology and Immunology of Russian Public Health
Moscow
Russian FederationK. V. Dobrenkov
Federal State Enterprise «Federal Research Clinical Center of Pediatric Hematology, Oncology and Immunology of Russian Public Health
Moscow
Russian FederationT. V. Shamanskaya
Federal State Enterprise «Federal Research Clinical Center of Pediatric Hematology, Oncology and Immunology of Russian Public Health; Moscow Regional Oncologic Dispensary
Moscow
Balashikha
Russian FederationYe. V. Samochatova
Federal State Enterprise «Federal Research Clinical Center of Pediatric Hematology, Oncology and Immunology of Russian Public Health
Moscow
Russian FederationA. G. Rumyantzev
Federal State Enterprise «Federal Research Clinical Center of Pediatric Hematology, Oncology and Immunology of Russian Public Health
Moscow
Russian FederationReferences
Supplementary files
